Marcus Schulz - 25 Aug 2023 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
29 Aug 2023, 17:54:40 UTC
Prior SEC filing
16 Aug 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Marcus Schulz

Key filing fact

Marcus Schulz filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 29 Aug 2023.

Key facts

  • This page summarizes Marcus Schulz's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 29 Aug 2023, 17:54.

Change

  • Previous filing in this sequence was filed on 16 Aug 2023.
  • Current net transaction value: -$3,814.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLFS transaction

Common Stock

Sale

Transaction value
$3,814
Shares
-347
Change %
-0.82%
Price
$10.99
Shares after
42,097
Date
25 Aug 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .